Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Hee Lim

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Oncology Research|September 25, 2023
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancerSung Hee Lim, Hee Jin Cho, Kyoung-Mee Kim, et al.
Asia-Pacific Journal of Clinical Oncology|April 1, 2016
Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinomaSung Hee Lim, In Gyu Hwang, Jun Ho Ji, et al.
Journal of Gastric Cancer|April 9, 2025
Pulmonary Tumor Thrombotic Microangiopathy Associated With Gastric Cancer: Clinical Characteristics and OutcomesTae-Se Kim, Soomin Ahn, Sung-A Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy TrialSung Hee Lim, Minae An, Hyuk Lee, et al.
Cancer Immunology Research|November 18, 2025
Distinct spatially resolved tumor microenvironment trajectories define benefit from ramucirumab plus pembrolizumab in refractory PD-L1+ gastric cancerSung Hee Lim, Minae An, You Jeong Heo, et al.
Cancer Genetics|July 19, 2025
Prevalence and clinical implications of PIK3CA aberrations across cancer types: A real-world next-generation sequencing approachJunkyu Kim, Hye-Lim Jang, Jung Young Hong, et al.
Cancer Research and Treatment|February 13, 2015
Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal CancerSeung Tae Kim, Tae Won Kim, Kyu-pyo Kim, et al.
Translational Cancer Research|February 4, 2022
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillageSun Hyun Bae, Kwang Hwan Cho, Young Seok Kim, et al.
Pathology, Research and Practice|August 6, 2024
Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysisDae-Ho Choi, Hye-Lim Jang, Sung Hee Lim, et al.
Japanese Journal of Clinical Oncology|April 9, 2013
Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphomaSung Hee Lim, Ji Yoon Lee, Ji Young Lee, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Oncology Research|September 25, 2023
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancerSung Hee Lim, Hee Jin Cho, Kyoung-Mee Kim, et al.
Asia-Pacific Journal of Clinical Oncology|April 1, 2016
Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinomaSung Hee Lim, In Gyu Hwang, Jun Ho Ji, et al.
Journal of Gastric Cancer|April 9, 2025
Pulmonary Tumor Thrombotic Microangiopathy Associated With Gastric Cancer: Clinical Characteristics and OutcomesTae-Se Kim, Soomin Ahn, Sung-A Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy TrialSung Hee Lim, Minae An, Hyuk Lee, et al.
Cancer Immunology Research|November 18, 2025
Distinct spatially resolved tumor microenvironment trajectories define benefit from ramucirumab plus pembrolizumab in refractory PD-L1+ gastric cancerSung Hee Lim, Minae An, You Jeong Heo, et al.
Cancer Genetics|July 19, 2025
Prevalence and clinical implications of PIK3CA aberrations across cancer types: A real-world next-generation sequencing approachJunkyu Kim, Hye-Lim Jang, Jung Young Hong, et al.
Cancer Research and Treatment|February 13, 2015
Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal CancerSeung Tae Kim, Tae Won Kim, Kyu-pyo Kim, et al.
Translational Cancer Research|February 4, 2022
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillageSun Hyun Bae, Kwang Hwan Cho, Young Seok Kim, et al.
Pathology, Research and Practice|August 6, 2024
Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysisDae-Ho Choi, Hye-Lim Jang, Sung Hee Lim, et al.
Japanese Journal of Clinical Oncology|April 9, 2013
Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphomaSung Hee Lim, Ji Yoon Lee, Ji Young Lee, et al.
Pageof 11